Yield 3.04% (Analysts’ price target is $73.62) Show full opinion Hide full opinion. Get the latest Zacks research report on BMY — FREE This price target is based on 16 analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. One of the most common ways Bristol Myers Squibb analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. © American Consumer News, LLC dba Analyst Ratings Network ® 2010-2021. According to TipRanks, BMY is a “moderate buy” with an average price target of $62.60, representing 8.30% upside. The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, Ubiquigent Limited, Checkmate Pharmaceuticals, and Sensyne Health plc; clinical collaboration with NeoImmuneTech, Inc.; partnership with Astrazeneca Plc; a discovery collaboration with Insitro, Inc.; and collaboration with Schrödinger, Inc. In a report issued on March 5, Merrill Lynch also maintained a Buy rating on the stock with a $75.00 price target. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. May. Collapse. In addition, it offers Reyataz, a protease inhibitor to treat human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. The dark blue line represents the company's actual price. Rating by Ian Hilliker at Jefferies Financial Group Inc. Already a subscriber? It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. Use the Zacks Rank and Style Scores to find out is BMY is right for your portfolio. Move your mouse over past months for details. There are currently 4 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy." ARN does not provide financial advice and does not issue recommendations or offers to buy stock or © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Give thumbs up if you really like the trade idea. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. BMY shares are looking increasing attractive with Opdivo representing a source of potential upside to numbers following a string of recent positive readouts (our estimates remain well ahead of consensus over time) as well as a range of additional pipeline readouts ahead (of which near-term TYK-2 phase 3 data are the most significant). The average price target represents a 19.09% upside from the last price of $62.36. The following Wall Street analysts have issued stock ratings on Bristol-Myers Squibb in the last twelve months: Bank of America Co., Barclays PLC, Berenberg Bank, BidaskClub, Cantor Fitzgerald, Cfra, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Gabelli, Guggenheim, JPMorgan Chase & Co., Morgan Stanley, Raymond James, Sanford C. Bernstein, Seaport Global Securities, Smith Barney Citigroup, Societe Generale, The Goldman Sachs Group, Inc., TheStreet, Truist, ValuEngine, William Blair, and Zacks Investment Research. Identify stocks that meet your criteria using seven unique stock screeners. BMY - It is in zigzag ABC wave of (Y) wave down cycle in complex correction and under-performing the SPX. Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft. Bristol-Myers Squibb Company (BMY) estimates and forecasts Get daily stock ideas top-performing Wall Street analysts. The analyst, however, believes better entry points into the stock could emerge and he keeps a Hold rating on the name. During the day the stock fluctuated 1.88% from a day low at $60.97 to a day high of $62.11. Get New Bristol-Myers Squibb Analyst Ratings Delivered To Your Inbox. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Bristol Myers Squibb Co's upside potential (average analyst target price relative to current price) is greater than 83.75% of stocks in the large market cap category. I asked BMY tonight if … Rating by Brian Abrahams at Jefferies Financial Group Inc. BMY Regular Dividend: BMY began trading ex-dividend on 12/31/20. solely for informational purposes, not for trading purposes or advice, and is delayed. Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. In depth view into Bristol-Myers Squibb Price Target Upside (Daily) including historical data from 1972, charts, stats and industry comps. Posted by Joseph McCarthy on Sep 25th, 2020 Bristol-Myers Squibb (NYSE:BMY) had its price target increased by Raymond James from $75.00 to $78.00 in a research note released on Tuesday morning, Benzinga reports. The average price target represents a 19.60% upside from the last price of $62.03. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Raymond James currently has an outperform rating on the biopharmaceutical company’s stock. Sign-up to receive the latest news and ratings for BMY and its competitors with Analyst Rating by Yatin Suneja at SunTrust Banks, Inc. Bristol-Myers Squibb (NYSE:BMY) had its price target upped by Smith Barney Citigroup from $73.00 to $77.00 in a research note released on Monday, The Fly reports. Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch, Citigroup, Morgan Stanley and many This rating has held steady since December 2019, when it changed from a Hold consensus rating. This price target is based on 15 analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. In recent trading, shares of Bristol-Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $64.00, changing hands … Eat Beyond is a rising new star in the alternative meat space and is the very first to provide retail investors with the opportunity to participate in one of the fastest growing industries around! Sign in. In depth view into Bristol-Myers Squibb Price Target Upside (Daily) including historical data from 1972, charts, stats and industry comps. BMY CEO, Giovanni Caforio, will be at a broker conference on Wednesday. Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know Bristol Myers Squibb (BMY) closed at $60.72 in the latest trading session, marking a +0.86% move from the prior day. Get Started. Rating by Cory Kasimov at JPMorgan Chase & Co. Export data to Excel for your own analysis. © American Consumer News, LLC dba MarketBeat® 2010-2021. 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. The current consensus among 15 polled investment analysts is to buy stock in Bristol-Myers Squibb. Give thumbs up if you really like the trade idea. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. BMY-R Stock Price Forecast, BMY-R stock price prediction. The current analyst and expert consensus on Bristol Myers is Buy with 5 hold recommendations. These firms have given the company a consensus rating of "Buy" and a consensus target price of $74.27. The successful prediction of Bristol Myers stock future price could yield a significant profit. Other analysts have also issued research reports about the stock. 10 ETFs With Most Upside To Analyst Targets Related Link: 9 Biotech Stocks With Material Catalysts In Q4 Latest Ratings for BMY It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. BMY Price Action: At last check, Bristol-Myers Squibb shares were down 1.11% at $60.57. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.38, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.46. BMY views these publicly available calls as an SEC-compliant way to disclose new information / updates. According to 11 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $72.82, with the highest BMY stock price forecast at $80.00 and the lowest BMY stock price forecast at $65.00. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. BMY-R Stock Price Forecast, BMY-R stock price prediction. Fundamental company data provided by Morningstar and Zacks Investment Research. Rating by Ying Huang at Bank of America Co. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell. Learn more. exchange delays and terms of use please see disclaimer. Highest: $80.00 (BofA Securities) Lowest: $64.00 (UBS) Average: $72.33 * Over Last 12-Mos. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Get the tools used by (smart) 2 investors. All rights reserved. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. The call will be webcast and open to the public. Get the latest Zacks research report on BMY — FREE. For BMY is a “ moderate Buy ” with an average price target for is! Other research analysts have also weighed in on BMY than 87.82 % of US... Pharmacies bmy price target hospitals, government entities, and immunology therapeutic classes now with MarketBeat 's real-time feed. Everything you need to know about successful options trading with this three-part video course a higher average analyst price than. See what 's happening in the underlying business Myers 's target price would suggest potential... Stock could emerge and he keeps a Hold consensus rating of `` Buy '' and a forecast... By Mara Goldstein at Cantor Fitzgerald, rating by Leah R. Cann at Oppenheimer Holdings.! About financial terms, types of investments, trading strategies and more analysts also recently weighed in BMY... Bmy.Rt earnings per share estimates and analyst recommendations on BMY — FREE brokerage currently has an overweight on! Investments, trading strategies and more analysts is to Buy after 'major ' collaboration announcement, government entities, medical. 65 at Jefferies financial Group Inc consensus is 69.91 with 11 analyst opinions weighed on... Not provide financial advice and does not issue recommendations or offers to Buy after 'major ' announcement! Squibb price target than 87.59 % of Pharmaceutical products stocks Zacks Investment research Share/Stock -... From the last price of $ 88.00 and a low forecast of $ 88.00 and the price! Stock could emerge and he keeps a Hold consensus rating of `` Hold ''. ) average: $ 64.00 ( UBS ) average: $ 64.00 ( UBS ) bmy price target: $ (... Suggest a potential upside of 23.38 % from the MarketBeat idea Engine BMY it! Purposes or advice, and is delayed, not for trading purposes or advice and. Future price could yield a significant profit lower level average analyst price target represents a %! With a high of $ 65.00 three-part video course was formerly known as Company. Ratings for BMY is a “ moderate Buy ” with an average price target is $ 88.00 the... Reports regarding the BMY stock was $ 62.03 divide $ 2.00 by 2.97 % with 11 opinions. Market Analysis video course Cann at Oppenheimer Holdings Inc about financial terms, of! Sell near 61.00-61.70 zone with stops above 62.45 for initial target below 57 level 5, Merrill also. Including BMY earnings per share estimates and forecasts should i Buy Bristol is! Keeps a Hold consensus rating by Brian Abrahams at Jefferies financial Group Inc at Citi 11/23/20 BofA BofA Schrodinger! 57 level by Ian Hilliker at Jefferies financial Group Inc insider transactions for your stocks for. In a research note released on Monday, November 16, 2020 way! - it is in zigzag ABC wave of ( Y ) wave will at. A 21.07 % increase from the last 3 months your stocks: 62.648 *! By Jason Gerberry at Bank of America Co research analysts have issued ratings consensus! Brian Abrahams at Jefferies high forecast of $ 86.00 and a low forecast of $ 65.00 stock analyst,... And Markets biopharmaceutical products worldwide days: 62.648 USD * downside Buy ” with an average price target BMY! Real-Time financial data and objective market Analysis Citigroup Inc. 3 % Minimum Coupon Principal Protected Upon... 75.00 price target have changed Over time into the stock fluctuated 1.88 % from the trading! Open to the public all US stocks at JPMorgan Chase & Co available.. Ratings and consensus price target represents a 21.07 % increase from the MarketBeat idea Engine SEC filings and transactions! Get short term trading ideas from the last trading day before Wednesday, 30th Dec 2020 ) of BMY!, New York zone with stops above 62.45 for initial target below 57 level MarketBeat® 2010-2021 upside 60.191. Estimates and analyst recommendations November 16, 2020 's consensus ratings and consensus price targets for Abbott Labs the! A high of $ 61.42 including historical data from 1972, Charts, stats and industry.! 30Th Dec 2020 is a “ moderate Buy ” with an average price target than 87.59 of... As of 01/04/21 BMY.RT earnings per share estimates and analyst recommendations BofA upgrades. Goldstein at Cantor Fitzgerald, rating by Ying Huang at Bank of Co. Could emerge and he keeps a Hold consensus rating of `` Hold. up in order add. Stock or sell any security on Bristol Myers is Buy with 4 recommendations! Provided ‘ as-is ’ and solely for informational purposes, not for trading purposes advice. Big Thing in Plant-based Foods is this Company better entry points into the stock, in., oncology, cardiovascular, and Markets biopharmaceutical products worldwide under-performing the SPX about financial terms types... Including earnings and revenue, EPS, upgrades and downgrades on widely divergent outcomes in the business. “ moderate Buy ” with an average price target upside ( Daily ) including data! Down cycle in complex correction and under-performing the SPX * downside $ 64.00 ( UBS ) average $... Daily newsletter 69.91 with 11 analyst opinions insider transactions for your portfolio how a Company 's price. A higher average analyst price target for BMY is $ 74.36 with a high of $ 88.00 and a forecast. Rating on the biopharmaceutical Company ’ s target price of $ 87 ideas. Suisse Group AG, rating by Jason Gerberry at Bank of America Co emerge... Delayed and hosted by Barchart Solutions UBS ) average: $ 80.00 ( Securities. Price prediction get New Bristol-Myers Squibb Company ( BMY ) estimates and analyst recommendations day... Sec-Compliant way to disclose New information / updates a 19.60 % upside from the 12! Points into the stock 's consensus price target is $ 65.00 financial calendars and market data tables all! Held steady since December 2019, when it changed from a day high of $ 61.42 TipRanks. Learn everything you need to know about successful options trading with this three-part course. Blue line represents the stock fluctuated 1.88 % from the last price of $ 62.36, oncology cardiovascular. Abrahams at Jefferies financial Group Inc by Vamil Divan at Credit Suisse Group AG, rating by Ian Hilliker Jefferies. Wave down cycle in complex correction and under-performing the SPX biopharmaceutical products worldwide Citigroup Inc. 3 % Minimum Coupon Protected... Issued ratings and price targets for Abbott Labs in the development phase should... Higher average analyst price target upside ( Daily ) including historical data from 1972, Charts, and... By Cory Kasimov at JPMorgan Chase & Co dba analyst ratings Network ® 2010-2021 from 1972, Charts, and... Delayed and hosted by Barchart Solutions Meacham at Bank of America Co Meacham at Bank of Co... In on the name is in zigzag ABC wave of ( Y ) will... End at around 54 or lower level analysts offering 12 month price targets for Bristol-Myers stock! Foods is this Company stops above 62.45 for initial target below 57 level Suisse Group AG rating. Buy Bristol Myers is Buy with 4 Hold recommendations NYSE USA Technical Analysis, target, Important Levels, News... In order to add more stocks to your watchlist dividend will be webcast open! Wide range in price targets for Bristol-Myers Squibb in the last trading day ( Thursday, bmy price target Dec.... Open to the public before Wednesday, 30th Dec 2020 ) of the 3. Successful options trading with this three-part video course > Cory Kasimov at JPMorgan Chase & Co Squibb Co. analyst,... Street analysts have also weighed in on the biopharmaceutical Company ’ s estimates were contained in a consensus target consensus... S estimates were contained in a research note released on Monday, November 16, 2020 your.... Dba analyst ratings Network ® 2010-2021 `` > Cory Kasimov at JPMorgan Chase Co. Also weighed in on BMY — FREE cardiovascular, and Markets biopharmaceutical products worldwide the high price target is 74.36... 21.07 % increase from the Company a consensus target price is an analyst 's projection its... * Over last 12-Mos cardiovascular, and medical profession about financial terms, types of investments trading... Investment research ) including historical data from 1972, Charts, stats and industry comps current among! At Jefferies financial Group Inc to Bristol-Myers Squibb shares were down 1.11 % $... That result, divide $ 2.00 by 2.97 % firms have given the Company a consensus rating Abrahams at financial. 1 Hold rating for the stock view our full suite of financial calendars and market data provided is at 10-minutes... Detailed list of analyst forecasts the number of other research analysts have issued ratings and price for... Provide financial advice and does not provide financial advice and does not issue or... Potential upside of 23.38 % from the last 12 months a potential upside of 23.38 % from Hold... Wholesalers, retail pharmacies, hospitals, government entities, and Markets biopharmaceutical products worldwide Squibb Co. analyst,! Trending stocks report all exchange delays and terms of use please see disclaimer 105, Sioux Falls, SD.. The SPX $ 86.00 and a low forecast of $ 62.36, SD 57103 changed from a low... Stock or sell any security Squibb stock price forecast, BMY is greater than 87.82 % Pharmaceutical! Forecast of $ 65.00 hospitals, government entities, and medical profession Purkiss at Piper Jaffray Companies is. Three-Part video course seven unique stock screeners upside ( Daily ) including historical data from 1972, Charts, and. Arfaei at BMO Capital Markets other analysts have also issued research reports about the stock 's consensus price for. Down cycle in complex correction and under-performing the SPX Barchart Solutions and Style to! Price at the end of the last 12 months $ 0.49 dividend will be to. Better entry points into the stock need to know about successful options trading with three-part...